Chronic administration of tibolone modulates anxiety-like behavior and enhances cognitive performance in ovariectomized rats

Hormones and Behavior

Volumn 61, Issue 1, 2012, Pages 76-83

  Espinosa Raya, Judith ^a   Neri Gómez, Teresa ^a,b   Orozco Suárez, Sandra ^b   Campos, María G ^b   Guerra Araiza, Christian ^b  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

Anxiety; Choline acetyl transferase; Hippocampus; Learning; Memory; Tibolone; Tryptophan hydroxylase

Indexed keywords

CHOLINE ACETYLTRANSFERASE; TIBOLONE; TRYPTOPHAN HYDROXYLASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR CHANGE; CHOLINERGIC SYSTEM; CHRONIC DRUG ADMINISTRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; ENZYME LOCALIZATION; FEMALE; HIPPOCAMPUS; LATENT PERIOD; MAZE TEST; MEMORY CONSOLIDATION; MENTAL PERFORMANCE; MENTAL TASK; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEROTONINERGIC SYSTEM; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CHOLINE O-ACETYLTRANSFERASE; COGNITION; ESTROGEN RECEPTOR MODULATORS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HIPPOCAMPUS; MAZE LEARNING; NORPREGNENES; OVARIECTOMY; RATS; TRYPTOPHAN HYDROXYLASE;

EID: 84855944876     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2011.10.005     Document Type: Article

References (91)

1. Aguiar R.B., Dickel O.E., Cunha R.W., Monserrat J.M., Barros D.M., Martinez P.E. Estradiol valerate and tibolone: effects on memory. Pharmacol. Biochem. Behav. 2006, 85:689-696.
2. Aguiar R.B., Dickel O.E., Cunha R.W., Monserrat J.M., Barros D.M., Martinez P.E. Estradiol valerate and tibolone: effects upon brain oxidative stress and blood biochemistry during aging in female rats. Biogerontology 2008, 9:285-298.
3. Barnes N.M., Sharp T. A review of central 5-HT receptors and their functions. Neuropharmacology 1999, 38:1083-1152.
4. Bertoglio L.J., Carobrez A.P. Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety. Behav. Brain Res. 2000, 108:197-203.
5. Bethea C.L., Lu N.Z., Gundlah C., Streicher J.M. Diverse actions of ovarian steroids in the serotonin neural system. Front. Neuroendocrinol. 2002, 23:41-100.
6. Blaustein J.D., Olster D.H., Tetel M.J. Heterogeneous regulation of steroid hormone receptors in the brain. Integr. Comp. Biol. 1993, 33:219-228.
7. Brinton R.D. Cellular and molecular mechanisms of estrogen regulation of memory function and neuroprotection against Alzheimer's disease: recent insights and remaining challenges. Learn. Mem. 2001, 8:121-133.
8. Brown T.J., Scherz B., Hochberg R.B., MacLusky N.J. Regulation of estrogen receptor concentrations in the rat brain: effects of sustained androgen and estrogen exposure. Neuroendocrinology 1996, 63:53-60.
9. Buhot M.C., Martin S., Segu L. Role of serotonin in memory impairment. Ann. Med. 2000, 32:210-221.
10. Cagnacci A., Mallus E., Tuveri F., Cirillo R., Setteneri A.M., Melis G.B. Effect of tibolone on glucose and lipid metabolism in postmenopausal women. J. Clin. Endocrinol. Metab. 1997, 82:251-253.
11. Campisi R., Marengo F.D. Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator. Cardiovasc. Drug Rev. 2007, 25:132-145.
12. Celik O., Erdem G., Hascalik S., Karakas H.M., Tamser M. Magnetic resonance spectroscopic comparison of the effects of resveratrol (3,40,5-trihydroxy stilbene) to conjugated equine estrogen, tibolone and raloxifene on ovariectomized rat brains. Eur. J. Obstet. Gynecol. Reprod. Biol. 2005, 120:73-79.
13. Cetinkaya M.B., Alper T., Kokcu A., Yanik F.F., Malatyalioglu E. Tibolone versus four estrogen replacement therapy protocols and plasma lipid levels in postmenopausal women. Int. J. Gynaecol. Obstet. 2002, 79:17-23.
14. Chakraborty T.R., Gore A.C. Aging-related changes in ovarian hormones, their receptors, and neuroendocrine function. Exp. Biol. Med. 2004, 229:977-987.
15. Chakraborty T.R., Ng L., Gore A.C. Age-related changes in estrogen receptor ß in rat hypothalamus: a quantitative analysis. Endocrinology 2003, 144:4164-4171.
16. Daniel J.M., Dohanich G.P. Acetylcholine mediates the estrogen-induced increase in NMDA receptor binding in CA1 of the hippocampus and the associated improvement in working memory. J. Neurosci. 2001, 21:6949-6956.
17. Deakin J.F.W., Graeff F.G. 5-HT and mechanisms of defence. J. Psychopharmacol. 1991, 5:305-315.
18. Decker M.W., McGaugh J.L. The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse 1991, 7:151-168.
19. De-Mello N., Carobrez A.P. Elevated T-maze as an animal model of memory: effects of scopolamine. Behav. Pharmacol. 2002, 13:139-148.
20. Diaz-Veliz G., Alarcon T., Espinoza C., Dussaubat N., Mora S. Ketanserin and anxiety levels: influence of gender, estrous cycle, ovariectomy and ovarian hormones in female rats. Pharmacol. Biochem. Behav. 1997, 58:637-642.
21. Dohanich G.P., Fader A.J., Javorsky D.J. Estrogen and estrogen-progesterone treatments counteract the effect of scopolamine on reinforced T-maze alternation in female rats. Behav. Neurosci. 1994, 108:988-992.
22. Espinosa-Raya J., Espinoza-Fonseca M., Picazo O., Trujillo-Ferrara J. Effect of a M1 allosteric modulator on scopolamine-induced amnesia. Med. Chem. 2007, 3:7-11.
23. Espinosa-Raya J., Plata-Cruz N., Neri-Gomez T., Camacho-Arroyo I., Picazo O. Effects of short-term hormonal replacement on learning and on basal forebrain ChAT and TrkA content in ovariectomized rats. Brain Res. 2011, 1375:77-84.
24. Everitt B.J., Robbins T.W. Central cholinergic systems and cognition. Annu. Rev. Psychol. 1997, 48:649-684.
25. Frye C.A., Petralia S.M., Rhodes M.E. Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3α, 5β-THP. Pharmacol. Biochem. Behav. 2000, 67:587-596.
26. Genazzani A.R., Bernardi F., Pluchino N., Giretti M.S., Begliuomini S., Casarosa E. Effect of tibolone administration on central and peripheral levels of allopregnanolone and β-endorphin in female rats. Menopause 2006, 13:57-64.
27. Genazzani A.R., Pluchino N., Luisi S., Luisi M. Estrogen, cognition and female ageing. Hum. Reprod. Update 2007, 13:175-187.
28. Gerhardt C.C., Heerikhuizen H. Functional characteristics of heterology expressed 5-HT receptors. Eur. J. Pharmacol. 1997, 334:1-23.
29. Gibbs R.B. Fluctuations in relative levels of choline acetyltransferase mRNA in different regions of the rat basal forebrain across the estrous cycle: effects of estrogen and progesterone. J. Neurosci. 1996, 16:1049-1055.
30. Gibbs R.B. Effects of estrogen on basal forebrain cholinergic neurons vary as a function of dose and duration of treatment. Brain Res. 1997, 757:10-16.
31. Gibbs R.B. Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function. Neuroscience 2000, 101:931-938.
32. Gibbs R.B. Basal forebrain cholinergic neurons are necessary for estrogen to enhance acquisition of a delayed matching-to-position T-maze task. Horm. Behav. 2002, 42:245-257.
33. Gibbs R.B. Estrogen therapy and cognition: a review of the cholinergic hypothesis. Endocr. Rev. 2010, 31:224-253.
34. Gibbs R.B., Nelson D., Anthony M.S., Clarkson T.B. Effects of long-term hormone replacement and of tibolone on choline acetyltransferase and acetylcholinesterase activities in the brains of ovariectomized, cynomologous monkeys. Neuroscience 2002, 113:907-914.
35. Gooyer M.E., Deckers G.H., Schoonen W.G.E.J., Verheul H.A.M., Kloosterboer H.J. Receptor profiling and endocrine interactions of tibolone. Steroids 2003, 68:21-30.
36. Graeff F.G., Viana M.B., Tomaz C. The elevated T maze, a new experimental model of anxiety and memory: effect of diazepam. Braz. J. Med. Biol. Res. 1993, 26:67-70.
37. Graeff F.G., Ferreira C.N., Zangrossi H. The elevated T-maze as an experimental model of anxiety. Neurosci. Biobehav. Rev. 1998, 23:237-246.
38. Halbreich U. Role of estrogen in postmenopausal depression. Neurobiology 1997, 48:S16-S19.
39. Haskell S.G., Richardson E.D., Horwitz R.I. The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature. J. Clin. Epidemiol. 1997, 50:1249-1264.
40. Heikkinen T., Puolivali J., Liu L., Rissanen A., Tanila H. Effects of ovariectomy and estrogen treatment on learning and hippocampal neurotransmitters in mice. Horm. Behav. 2002, 41:22-32.
41. Keenan P.A., Ezzat W.H., Ginsburg K., Moore G.J. Prefrontal cortex as the site of estrogen's effect on cognition. Psychoneuroendocrinology 2001, 26:577-590.
42. Kloosterboer H.J. Tibolone: a steroid with a tissue-specific mode of action. J. Steroid Biochem. Mol. Biol. 2001, 76:231-238.
43. Koss W.A., Gehlert D.R., Shekhar A. Different effects of subchronic doses of 17β-estradiol in two ethologically based models of anxiety utilizing female rats. Horm. Behav. 2004, 46:158-164.
44. Krezel W., Dupont S., Krust A., Chambon P., Chapman P.F. Increased anxiety and synaptic plasticity in estrogen receptor beta-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:12278-12282.
45. Lasiuk G.C., Hegadoren K.M. The effects of estradiol on central serotonergic systems and its relationship to mood in women. Biol. Res. Nurs. 2007, 9:147-160.
46. Lerner A.J. Commentary: women and Alzheimer's Disease. J. Clin. Endocrinol. Metab. 1999, 84:1830-1834.
47. Levkovitz Y., Caftori R., Avital A., Richter-Levin G. The SSRIs drug fluoxetine, but not the noradrenergic tricyclic drug desipramine, improves memory performance during acute major depression. Brain Res. Bull. 2002, 58:345-350.
48. Luine V.N. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp. Neurol. 1985, 89:484-490.
49. Linstow R.E., Platt B. Biochemical dysfunction and memory loss: the case of Alzheimer's dementia. Cell. Mol. Life Sci. 1999, 55:601-616.
50. Lund T.D., Rovis T., Chung W.C.J., Handa R.J. Novel actions of estrogen receptor-ß on anxiety-related behaviors. Endocrinology 2005, 146:797-807.
51. Maggi A., Peres J. Progesterone and estrogens in rat brain modulation of GABA (gamma-aminobutyric acid) receptor activity. Eur. J. Pharmacol. 1984, 165-168.
52. Manuel-Apolinar L., Meneses A. 8-OH-DPAT facilitated memory consolidation and increased hippocampal and cortical cAMP production. Behav. Brain Res. 2004, 148:179-184.
53. McEntee W.J., Crook T.H. Cholinergic function in the aged brain: implications for treatment of memory impairments associated with aging. Behav. Pharmacol. 1992, 3:327-336.
54. McEwen B.S. The molecular and neuroanatomical basis for estrogen effects in the central nervous system. J. Clin. Endocrinol. Metab. 1999, 84:1790-1797.
55. Meneses A. 5-HT system and cognition. Neurosci. Biobehav. Rev. 1999, 23:1111-1125.
56. Meneses A. Tianeptine: 5-HT uptake sites and 5-HT1-7 receptors modulate memory formation in an autoshaping Pavlovian/instrumental task. Neurosci. Biobehav. Rev. 2002, 26:309-319.
57. Meneses A. A pharmacological analysis of an associative learning task: 5-HT(1) to 5-HT (7) receptor subtypes function on a Pavlovian/instrumental autoshaped memory. Learn. Mem. 2003, 10:363-372.
58. Meneses A., Hong E. A pharmacological analysis of serotonergic receptors: effects of their activation or blockade in learning. Prog. Neuropsychopharmacol. Biol. Psychiatry 1997, 21:273-296.
59. Meneses A., Terrón J.A. Role of 5-HT (1A) and 5-HT (7) receptors in the facilitatory response induced by 8-OH-DPAT on learning consolidation. Behav. Brain Res. 2001, 121:21-28.
60. Mesulam M.M. The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease. Prog. Brain Res. 1996, 109:285-297.
61. Moss R.L., Gu Q. Estrogen: mechanisms for a rapid action in CA1 hippocampal neurons. Steroids 1999, 64:14-21.
62. Nabekura J., Oomura Y., Minami T., Mizuno Y., Fukuda A. Mechanism of the rapid effect of 17b-estradiol on medial amygdala neurons. Science 1986, 233:226-228.
63. Nilsen J., Brinton R.D. Impact of progestins on estradiol potentiation of the glutamate calcium response. Neuroreport 2002, 13:825-830.
64. Palomba S., Orio F.J., Falbo A., Oppedisano R., Tolino A., Zullo F. Tibolone reverses the cognitive effects caused by leuprolide acetate administration, improving mood and quality of life in patients with symptomatic uterine leiomyomas. Fertil. Steril. 2008, 90:165-173.
65. Pandaranandaka J., Poonyachoti S., Kalandakanond-Thongsong S. Anxiolytic property of estrogen related to the changes of the monoamine levels in various brain regions of ovariectomized rats. Physiol. Behav. 2006, 87:828-835.
66. Pandaranandaka J., Poonyachoti S., Kalandakanond-Thongsong S. Differential effects of exogenous and endogenous estrogen on anxiety as measured by elevated T-maze in relation to the serotonergic system. Behav. Brain Res. 2009, 198:142-148.
67. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, San Diego. Fourth ed.
68. Pinheiro S.H., Zangrossi H., Del Ben C.M., Graeff F.G. Elevated mazes as animal models of anxiety: effects of serotonergic agents. An. Acad. Bras. Cienc. 2007, 79:71-85.
69. Pu Z:., Krugers H.J., Joëls M. β-Adrenergic facilitation of synaptic plasticity in the rat basolateral amygdala in vitro is gradually reversed by corticosterone. Learn. Mem. 2009, 16:155-160.
70. Qiu J., Bosch M.A., Rønnekleiv O.K., Kloosterboer H.J., Kelly M.J. Tibolone rapidly attenuates the GABAB response in hypothalamic neurones. J. Neuroendocrinol. 2008, 20:1310-1318.
71. Richter-Levin G. The amygdala, the hippocampus, and emotional modulation of memory. Neuroscientist 2004, 10:31-39.
72. Sanson L.T., Carobrez A.P. Long-lasting inhibitory avoidance acquisition in rats submitted to the elevated T-maze model of anxiety. Behav. Brain Res. 1999, 101:59-64.
73. Sarter M., Hagan J., Dudchenko P. Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I. Psychopharmacology (Berl) 1992, 107:144-159.
74. Sherwin B.B. Estrogen and cognitive functioning in women. Proc. Soc. Exp. Biol. Med. 1998, 217:17-22.
75. Sherwin B.B. Estrogen and cognitive functioning in women. Endocr. Rev. 2003, 24:133-151.
76. Shobe J. The role of PKA, CaMKII, and PKC in avoidance conditioning: permissive or instructive?. Neurobiol. Learn. Mem. 2002, 77:291-312.
77. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., Hendrix S.L., Jones B.N., Assaf A.R., Jackson R.D., Kotchen J.M., Wassertheil-Smoller S., Wactawski-Wende J. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003, 289:2651-2662.
78. Simpkins J.W., Green P.S., Gridley K.E., Singh M., de Fiebre N.C., Rajakumar G. Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease. Am. J. Med. 1997, 103:19S-25S.
79. Skoog I., Gustafson D. HRT and dementia. J. Epidemiol. Biostat. 1999, 4:227-251.
80. Smith R.G., Betancourt L., Sun Y. Molecular, endocrinology and physiology of the aging central nervous system. Endocr. Rev. 2005, 26:203-250.
81. Steckler T., Andrews J.S., Marten P., Turner J.D. Effects of NBA lesions with two neurotoxins on spatial memory and autoshaping. Pharmacol. Biochem. Behav. 1993, 44:877-889.
82. Tomie A., Aguado A.S., Pohorecky L.A., Benjamin D. Individual differences in Pavlovian autoshaping lever pressing in rats predicts stress-induced corticosterone release and mesolimbic levels of monoamines. Pharmacol. Biochem. Behav. 2001, 65:509-517.
83. Toufexis D.J., Myers K.M., Bowser M.E., Davis M. Estrogen disrupts the inhibition of fear in female rats, possibly through the antagonistic effects of estrogen receptor (ER) and ERß. J. Neurosci. 2007, 27:9729-9735.
84. Verheul H.A., Kloosterboer H.J. Metabolism of exogenous sex steroids and effect on brain functions with a focus on tibolone. J. Steroid Biochem. Mol. Biol. 2006, 102:195-204.
85. Verheul H.A., Timmer C.J., Kloosterboer H.J. Pharmacokinetic parameters of sulfated tibolone metabolites in postmenopausal women after single and multiple doses of tibolone. Clin. Pharmacol. Ther. 2007, 81:573-579.
86. Viana M.B., Tomaz C., Graeff F.G. The elevated T-maze: a new animal model of anxiety and memory. Pharmacol. Biochem. Behav. 1994, 49:549-554.
87. Wilensky A.E., Schafe G.E., LeDoux J.E. The amygdala modulates memory consolidation of fear-motivated inhibitory avoidance learning but not classical fear conditioning. J. Neurosci. 2000, 20:7059-7066.
88. Wenk G.L. The nucleus basalis magnocellularis cholinergic system: one hundred years of progress. Neurobiol. Learn. Mem. 1997, 67:85-95.
89. Wu J., Zhu Y., Wu J. Effects of estrogen and estrogenic compounds on cognition in ovariectomized rats. Climacteric 2008, 11:212-220.
90. Yoshitake K., Yokota K., Kasugai Y., Kagawa M., Sukamoto T., Nakamura T. Effects of 16 weeks of treatment with tibolone on bone mass and bone mechanical and histomorphometric indices in mature ovariectomized rats with established osteopenia on a low-calcium diet. Bone 1999, 25:311-319.
91. Zangrossi H., Graeff F.G. A behavioral validation of the elevated T-maze: a new animal model of anxiety. Brain Res. Bull. 1997, 44:1-5.